We are live on ! Find out more
ADVM

Adverum Biotechnologies
ADVM

Delisted

ADVM was delisted on the 8th of December, 2025.

Back to rankings

58 hedge funds and large institutions have $49.5M invested in Adverum Biotechnologies in 2017 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 15 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

52% more capital invested

Capital invested by funds: $32.5M → $49.5M (+$16.9M)

13% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 15

0.1% more ownership

Funds ownership: 3.04% → 3.14% (+0.1%)

8% less funds holding

Funds holding: 63 → 58 (-5)

33% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 12

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $19K

Holders
58
Holders Change
-5
Holders Change %
-7.94%
% of All Funds
1.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
17
Reduced
15
Closed
12
Calls
–
Puts
$19K
Net Calls
-$19K
Net Calls Change
-$6K

Top Buyers

Rank Fund Capital Flow
1
SC
Sessa Capital
New York
+$1.3M
2
Renaissance Technologies
Renaissance Technologies
New York
+$1.16M
3
MP
Mangrove Partners
Connecticut
+$1.15M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$988K
5
TCM
Tekla Capital Management
Massachusetts
+$833K

Top Sellers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
-$947K
2
NI
Numeric Investors
Massachusetts
-$804K
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$654K
4
AIC
AWM Investment Company
New York
-$500K
5
Goldman Sachs
Goldman Sachs
New York
-$420K
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$7.3M – – –
Renaissance Technologies
2
Renaissance Technologies
New York
$6.72M +$1.16M +41,653 +29%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$5.74M -$654K -23,580 -13%
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.3M +$988K +35,611 +65%
EC
5
EcoR1 Capital
California
$2.79M -$309K -11,150 -13%
SC
6
Sessa Capital
New York
$2.33M +$1.3M +46,722 +272%
6CM
7
683 Capital Management
New York
$2.01M +$347K +12,500 +29%
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$1.97M +$653K +23,536 +77%
Primecap Management
9
Primecap Management
California
$1.77M -$17.2K -620 -1%
MP
10
Mangrove Partners
Connecticut
$1.51M +$1.15M +41,384 New
BlackRock
11
BlackRock
New York
$1.44M +$159K +5,724 +17%
TCM
12
Tekla Capital Management
Massachusetts
$1.09M +$833K +30,008 New
VMI
13
VHCP Management II
New York
$1.02M – – –
NI
14
Numeric Investors
Massachusetts
$983K -$804K -28,975 -52%
Millennium Management
15
Millennium Management
New York
$909K -$947K -34,113 -58%
Connor, Clark & Lunn Investment Management (CC&L)
16
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$835K -$1.67K -60 -0.3%
California Public Employees Retirement System
17
California Public Employees Retirement System
California
$705K +$132K +4,768 +33%
OAM
18
Oxford Asset Management
United Kingdom
$703K -$89.4K -3,223 -14%
Deutsche Bank
19
Deutsche Bank
Germany
$680K +$243K +8,761 +89%
BCM
20
Bridgeway Capital Management
Texas
$671K – – –
JAM
21
JW Asset Management
Florida
$652K – – –
RPAM
22
Rhenman & Partners Asset Management
Sweden
$562K – – –
JP Morgan Chase
23
JP Morgan Chase
New York
$355K +$84K +3,025 +42%
Schroder Investment Management Group
24
Schroder Investment Management Group
United Kingdom
$350K -$26.3K -948 -9%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$347K – – –
1
2 3

ADVM Hedge Fund Activity: Q3 2017 in Review

58 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Adverum Biotechnologies (ADVM) for Q3 2017, worth a combined $49.5M — up 52% from $32.5M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ADVM and 8 opened new positions — a net loss of 4 holders — while 15 trimmed existing stakes and 17 added.

The largest buyer was Sessa Capital, adding an estimated $1.3M. The largest seller was Millennium Management, cutting an estimated $947K.

  • 58 institutional investors held Adverum Biotechnologies (ADVM) as of Q3 2017, down from 63 in Q2 2017.
  • Funds reported $49.5M of Adverum Biotechnologies stock for Q3 2017, up 52% quarter-over-quarter.
  • 8 funds opened new Adverum Biotechnologies positions in Q3 2017 and 12 closed out, a net change of -4 holders.
  • The largest Adverum Biotechnologies buyer in Q3 2017 was Sessa Capital, an estimated $1.3M added.
  • The largest Adverum Biotechnologies seller in Q3 2017 was Millennium Management, an estimated $947K sold.

Based on aggregated 13F filings for Q3 2017.